December 25, 2025 - 03:17

AI chip startup Groq announced on Wednesday that it has entered into a licensing agreement with Nvidia, a significant move in the rapidly evolving tech landscape. While the specific terms of the transaction have not been publicly disclosed, reports suggest that Nvidia is investing approximately $20 billion in cash for Groq's assets.
Despite this substantial investment, Groq emphasized in a blog post that it will maintain its independence and continue to operate as a separate entity. The company also confirmed that its cloud business will remain active, allowing it to serve its existing clients and explore new opportunities in the AI sector.
Groq, known for its innovative approaches to chip design, aims to enhance its capabilities through this partnership while preserving its unique identity in the competitive market. This collaboration is expected to bolster Nvidia's position in the AI chip arena, as both companies look to capitalize on the growing demand for advanced computing solutions.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...